Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: MMP Ownership

According to Moore's complaint

Sixth Cause of Action (pg. 24 line 18)

Breach of Contract - allowing the submission and recordation at the PTO of documents claiming and supposedly establishing assignee status and ownership rights in TPL of patents

Is this part not about ownership of the MMP portfolio?

Moore is asking the court to declare void and rescind the ComAg and its amendments. Moore asked for and received oral assurance from Leckrone that the ComAg was a licensing agreement only.

Share
New Message
Please login to post a reply